The diagnosis of diabetes is changing: How implementation of hemoglobin A1c will impact clinical laboratories

Clinical Chemistry

Volumn 55, Issue 9, 2009, Pages 1612-1614

  Sacks, David B ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

CLINICAL LABORATORY; DIABETES MELLITUS; DIABETIC MICROANGIOPATHY; DIABETIC RETINOPATHY; DIAGNOSTIC ACCURACY; GLUCOSE BLOOD LEVEL; GOLD STANDARD; HIGH RISK POPULATION; HUMAN; HYPERGLYCEMIA; ORAL GLUCOSE TOLERANCE TEST; SHORT SURVEY; STANDARDIZATION; SYMPTOMATOLOGY;

BIOLOGICAL MARKERS; BLOOD GLUCOSE; CLINICAL LABORATORY TECHNIQUES; DIABETES MELLITUS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS;

EID: 69549131233     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2009.132704     Document Type: Short Survey

References (5)

1. International Expert Committee. International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes. Diabetes Care 2009;32:1327-1334
2. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group. Diabetes 1979;28:1039-1057
3. American Diabetes Association. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20:1183-1197 (Pubitemid 27274286)
4. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Part 1: diagnosis and classification of diabetes mellitus. Geneva: World Health Organization; 1999.
5. American Diabetes Association. Standards of medical care in diabetes - 2009. Diabetes Care 2009;32(Suppl 1):S13-61.